No. 1 online shop for research peptides in Europe

Pre-Filled Pen

Research use only

Cartalax (Peptide Bioregulator) 20mg / 2mL

€69.00

VAT included. Shipping calculated at checkout.

1

In stock

  • ≥99% purity
  • HPLC & LC-MS analysed
  • Stabilised formula
  • The world's first brand of peptides in a pen

Secure delivery

Secure delivery with FedEx within 1–2 business days after payment confirmation

Payment methods

  • Bank transfer
How the pen worksVideo in English

What is Cartalax?

Cartalax (Ala-Glu-Asp) is a synthetic tripeptide made up of the amino acids alanine, glutamic acid and aspartic acid. It belongs to the family of short regulatory peptides, which are characterised by their ability to interact with the genetic apparatus and regulate the expression of specific genes.

Cartalax has mainly been studied in connection with joint health and cartilage tissue. Thanks to its low molecular weight, it easily penetrates cells and stimulates processes associated with the restoration, regeneration and protection of connective tissue. This makes it a valuable tool in studies focused on the musculoskeletal system and cell biology.

What are the benefits of Cartalax?

Cartalax is a peptide that shows a number of potential benefits in various fields of research:

1. Support for joint health

The main benefit of Cartalax is its support for joint function. It stimulates regenerative processes in cartilage tissue and helps preserve the elasticity and resilience of the joints.

2. Improvement of cellular regeneration

Through its influence on gene expression, Cartalax activates the synthesis of proteins involved in the restoration and regeneration of connective tissue.

3. Reduction of oxidative stress

Cartalax has been studied as a peptide that can reduce the negative effects of free radicals on joints and connective tissue. This makes it particularly important for maintaining cellular health.

4. Support for the immune system

The peptide may play a role in regulating immunological processes by supporting the balance of inflammatory responses, which often affect the joints.

5. Optimisation of metabolic processes

Cartalax supports cellular metabolism and energy efficiency in cartilage and connective tissue. This is crucial for maintaining load-bearing capacity and regenerative mechanisms.

6. Potential for healthy ageing

The combination of antioxidant protection, cellular regeneration and the preservation of joint function makes Cartalax an interesting peptide in studies on healthy ageing and maintaining mobility.

Mechanism of action of Cartalax:

The mechanism of action of Cartalax is based on its ability to interact with DNA and regulate the expression of genes responsible for cell growth and regeneration. Because of its low molecular weight, the tripeptide penetrates cells directly and activates the synthesis of proteins involved in stabilising cellular structures and regenerating cartilage tissue.

In addition, Cartalax can stabilise cell membranes, reduce the effects of free radicals and improve communication between cells. These mechanisms are crucial for maintaining the health of joints and connective tissue.

Correct use and dosage of Cartalax:

Recommended dose: 20 units once daily, subcutaneously

1 unit = 100 mcg

Total amount in one pen: 200 units (20 mg)

The length of the cycle may vary depending on the specific condition and the individual requirements of the research protocol.

Research on Cartalax in various fields:

Cartalax has been studied in numerous lines of research, including:

  • Orthopaedics and rheumatology – focus on maintaining joint function and regenerating cartilage tissue.
  • Gerontology – interest in its role in maintaining mobility and healthy ageing.
  • Immunology – considered a potential immunomodulator that balances inflammatory processes.
  • Molecular biology – studied because of its influence on gene expression and protein synthesis.
  • Antioxidant research – focus on its ability to protect connective tissue from oxidative stress.

These studies underline the importance of Cartalax as a valuable tool for scientific work in the field of joint and cellular health.

Possible side effects of Cartalax:

Cartalax is generally considered well tolerated in research applications. Potential side effects are rare and usually mild:

  • Slight redness or irritation at the injection site.
  • Headache – short-lived and of low intensity.
  • Tiredness – some users may experience temporary changes in energy levels.
  • Slight changes in sleep – mostly temporary.
  • Changes in appetite – rare and minor.

Overall, the available data suggest that Cartalax has a favourable tolerability profile and is well suited for inclusion in research protocols.

More from Peptides

Shopping information

Delivery

Delivered within 1–2 business days after your payment has been confirmed.

  • Shipped with FedEx
  • Shipping costs: €8.90
Shipping policy

Payment

  • Bank transfer

Pay securely by bank transfer. Your order is dispatched as soon as your payment has been confirmed.

For research use only

For scientific, laboratory, analytical and research use only, including as a reference standard in HPLC analyses – not for use in humans or animals.

Read more

All products are intended solely and exclusively for scientific, laboratory, analytical and research purposes, including use as reference standards in HPLC analyses. They are not intended for use in humans or animals, including for the diagnosis, treatment or prevention of disease, and are not approved medicinal products.

Contact & service

Questions about an order, delivery or a product? Our customer service team is happy to help.

ContactFAQ